Go to the list of all blogs
Joma Foster's Avatar
published in Blogs
Aug 03, 2026
Bloom Energy (BE): Can the Stock Rally +46% Back to the $300 Level?

Bloom Energy (BE): Can the Stock Rally +46% Back to the $300 Level?

Key Takeaways

  • Target in focus: Bloom Energy shares closed at $205.81 on July 31, 2026, meaning the stock would need to rally approximately 46% to reclaim the psychologically significant $300 level it first surpassed in June 2026.
  • Strongest bullish factors: A $25 billion expanded partnership with Brookfield Asset Management, a massive Oracle contract covering up to 2.8 gigawatts, and second-quarter revenue that topped $1 billion for the first time in company history.
  • Biggest obstacles: A stretched valuation with a trailing P/E ratio above 260, a recent short-seller report targeting the company's scandium supply chain, and a 29% decline over the past month that has damaged near-term momentum.
  • Key levels to watch: The $200 area represents a psychological support zone; resistance sits near $230–$250, where multiple prior swing lows were established; $300 remains the primary upside target discussed by both analysts and retail investors.
  • Bottom line: Reaching $300 is achievable if Bloom Energy continues converting its enormous backlog into revenue while defending its supply-chain narrative, but the path requires restored investor confidence after a sharp correction from all-time highs.

Why the $300 Mark Matters for Bloom Energy

Bloom Energy Corporation (BE), a San Jose-based manufacturer of solid oxide fuel cell systems for on-site power generation, has been one of the most volatile and closely watched names in the clean energy sector. After surging more than 450% over the past twelve months, the stock hit an all-time high of $345.85 on June 22, 2026, before a sharp pullback erased roughly 42% of its value in a matter of weeks.

The $300 level carries both psychological and technical significance. It represents a round-number threshold that captured widespread attention from retail investors and financial media when the stock first crossed above it in early June. Articles asking "Should You Buy Bloom Energy While It's Below $300?" appeared across major financial platforms including Nasdaq and The Motley Fool, reflecting genuine investor interest in that specific price point. With shares now trading well below that mark, the question of whether BE can reclaim $300 has become one of the most pressing debates surrounding the stock. I also checked recent patterns using Tickeron’s AI Pattern Search Engine to see how similar moves have played out in the past.

What Could Drive BE Back Toward $300

The single most powerful catalyst behind Bloom Energy's extraordinary run has been the artificial intelligence infrastructure build-out. Data centers require enormous amounts of reliable, always-on electricity, and traditional utility grids simply cannot expand fast enough to meet that demand. New transmission lines can take four to eight years to install, while Bloom's fuel cell servers can be deployed on-site in as little as 90 days.

In late June 2026, Bloom Energy expanded its partnership with BAM (Brookfield Asset Management) from $5 billion to $25 billion, a fivefold increase that signals deep institutional conviction in the company's technology. Additionally, ORCL (Oracle) has committed to deploying up to 2.8 gigawatts of Bloom's fuel cell capacity across its cloud infrastructure. These contracts provide a multi-year revenue runway that fundamentally changes the company's growth trajectory.

Bloom's second-quarter 2026 results underscore the operational momentum: revenue reached $1.07 billion, up 166% year over year, and management raised full-year revenue guidance to between $3.9 billion and $4.2 billion. Morgan Stanley estimates the equipment backlog now exceeds $8 billion. If the company continues executing at this pace, the fundamental case for a return to $300 strengthens considerably. From what I see, the backlog conversion will be key to watch.

What Could Prevent the Move

The most immediate headwind is valuation. Even after the recent pullback, BE trades at a trailing P/E ratio above 260 and a price-to-sales ratio near 19. That leaves almost no room for execution missteps, guidance misses, or external shocks.

On July 7, 2026, Hunterbrook Capital disclosed a short position targeting Bloom's scandium oxide supply chain. Scandium is a critical material in the company's solid oxide fuel cells, and Hunterbrook alleged inconsistencies regarding Bloom's claimed independence from Chinese rare earth sources. While management quickly responded—COO Satish Chitoori published a public statement affirming the supply chain can support 25 gigawatts of production—the episode reminded investors that premium-multiple stocks are acutely vulnerable to credibility challenges.

Competition also deserves attention. Hyperscalers are not betting exclusively on fuel cells. Nuclear developers, battery storage manufacturers, and traditional natural gas generators are all competing for the same AI power market. Bloom does not own the space; it participates in it. Any sign that a major customer is diversifying suppliers could pressure the stock.

Analyst Opinions and Price Targets

Wall Street remains cautiously constructive. According to S&P Global, 29 analysts covering Bloom Energy have a consensus rating of "Buy" with an average 12-month price target of $273.51, representing roughly 33% upside from current levels. The high target sits at $390, while the low target is $97—an unusually wide spread that reflects genuine disagreement about the company's prospects.

Notable bullish voices include UBS and Evercore ISI, both at $350, and J.P. Morgan at $346. Morgan Stanley maintains an Overweight rating with a $310 base case and a $520 bull case. On the more cautious side, Wells Fargo carries an Equal Weight rating with a $217 target, while Jefferies holds at Hold with a $246 target. BMO Capital sits at $279 with a Hold rating. The divergence between bullish and cautious analysts largely hinges on whether Bloom's revenue growth can ultimately justify its premium valuation.

Technical Landscape

From a technical perspective, BE presents a mixed picture. The stock remains approximately 138% higher year to date, so the long-term uptrend is intact despite recent weakness. The $200 area has emerged as a near-term psychological support zone, while the $230–$250 range represents a cluster of prior swing levels that would need to be cleared before any sustained move toward $300 can develop.

The stock's beta of 2.23 confirms what investors already know: BE is prone to violent swings in both directions. The 52-week range spans from roughly $25 to $351, a testament to the explosive volatility that defines this name. Any return to $300 would likely require a catalyst—such as a stronger-than-expected earnings report, a new hyperscaler contract announcement, or a resolution to the scandium supply-chain narrative that decisively favors the company. I’m watching the technical levels closely here.

Using Tickeron’s AI Daily Buy/Sell Signals

Traders monitoring Bloom Energy and other volatile names may benefit from tools that cut through the noise. Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously scan thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on real-time changes in technical behavior, market conditions, and AI-driven pattern recognition. For a stock as fast-moving as BE, where sentiment can shift dramatically in a single session, these signals can help traders identify opportunities, manage existing positions, and stay ahead of changing market trends without manually tracking every chart. I have found them useful for structuring decisions in high-volatility environments like this one.

Final Assessment

Can Bloom Energy reach $300? The question is realistic, but the answer depends on a convergence of factors. The company's underlying growth story—fueled by AI data center demand, a deep backlog, and landmark partnerships with Brookfield and Oracle—provides a credible foundation. Analysts at major firms have published targets well above $300, and the company is generating positive operating income and free cash flow for the first time in its history.

However, the stock's premium valuation means any stumble—whether operational, competitive, or narrative-driven—could delay or derail a return to $300. The short-seller attack, while contested, has introduced uncertainty that will likely persist until the next earnings report provides fresh data. Investors should monitor backlog conversion rates, gross margin trends, manufacturing capacity expansion plans, and any new customer announcements. A return to $300 is plausible, but it will require Bloom Energy to continue delivering flawless execution while defending the integrity of its supply chain and competitive position.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: BE

BE's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for BE turned positive on August 03, 2026. Looking at past instances where BE's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BE's RSI Indicator exited the oversold zone, of 35 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on August 03, 2026. You may want to consider a long position or call options on BE as a result. In of 73 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BE advanced for three days, in of 313 cases, the price rose further within the following month. The odds of a continued upward trend are .

BE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 59 cases where BE's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The 10-day moving average for BE crossed bearishly below the 50-day moving average on July 09, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for BE entered a downward trend on August 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock slightly better than average.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: BE's P/B Ratio (38.610) is very high in comparison to the industry average of (8.012). P/E Ratio (274.299) is within average values for comparable stocks, (124.144). Projected Growth (PEG Ratio) (0.886) is also within normal values, averaging (1.366). Dividend Yield (0.000) settles around the average of (0.010) among similar stocks. P/S Ratio (19.455) is also within normal values, averaging (9.854).

Notable companies

The most notable companies in this group are Bloom Energy Corp (NYSE:BE), Plug Power (NASDAQ:PLUG), FuelCell Energy Inc (NASDAQ:FCEL), GrafTech International Ltd (NYSE:EAF).

Industry description

The industry produces a diverse range of electricity-powered equipment, appliances and components, catering to both households and industries. The products include power, distribution and specialty transformers; electric motors, generators and motor-generator sets; switchgear and switchboard apparatus; light bulbs, tubes, fittings and electric signs etc. Consumer income, construction spending, and industrial production are major drivers of demand for this industry’s products. Large companies tend to have economies of scale in production, marketing, and distribution, while smaller companies can potentially carve out their own market through niche or specialty offerings. The US electrical products manufacturing industry includes about 5,700 establishments (single-location companies and units of multi-location companies) with combined annual revenue of about $125 billion. (according to a study published in First Research). Emerson Electric Co., Hubbell Incorporated and Eaton Corporation plc are major electrical products makers in the U.S.

Market Cap

The average market capitalization across the Electrical Products Industry is 5.87B. The market cap for tickers in the group ranges from 457 to 300.34B. CYATY holds the highest valuation in this group at 300.34B. The lowest valued company is NXUR at 457.

High and low price notable news

The average weekly price growth across all stocks in the Electrical Products Industry was 3%. For the same Industry, the average monthly price growth was -1%, and the average quarterly price growth was -2%. OESX experienced the highest price growth at 90%, while ELPW experienced the biggest fall at -99%.

Volume

The average weekly volume growth across all stocks in the Electrical Products Industry was -11%. For the same stocks of the Industry, the average monthly volume growth was 31% and the average quarterly volume growth was -26%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 56
P/E Growth Rating: 71
Price Growth Rating: 61
SMR Rating: 84
Profit Risk Rating: 83
Seasonality Score: -15 (-100 ... +100)
View a ticker or compare two or three
BE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of on-site electric power solutions

Industry ElectricalProducts

Profile
Details
Industry
Electrical Products
Address
4353 North First Street
Phone
+1 408 543-1500
Employees
2377
Web
https://www.bloomenergy.com
Interact to see
Advertisement
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.